Find out what your body needs with clinical support.

Dual-pathway weight loss therapy targeting both GLP-1 and GIP receptors for superior fat loss vs. semaglutide alone.

GHRH analog that selectively reduces visceral adipose tissue while preserving lean mass. Strong evidence base for metabolic and body composition benefits.

Long-acting PDE5 inhibitor. Improves erectile function and may support cardiovascular and prostate health at low daily doses.

Gold-standard injectable TRT. Available in MCT, grapeseed, and cottonseed oil. Male and female dosing supported.

Maintains testicular function and fertility during TRT. Also used standalone for LH stimulation and mild testosterone support.

Pharmaceutical-grade EPA/DHA concentrate (generic Lovaza). Used to lower elevated triglycerides and as an adjunct in cardiometabolic risk-reduction protocols.

Cholesterol absorption inhibitor that lowers LDL when statins alone aren't enough, or as a statin-sparing option for those who don't tolerate statins.

Long-acting ergot-derived dopamine D2 receptor agonist for hyperprolactinemia and prolactinomas.

Third-generation steroidal (irreversible/suicide) aromatase inhibitor.

Synthetic mineralocorticoid for aldosterone replacement in primary adrenal insufficiency.

Biosynthetic FSH for Sertoli cell stimulation and spermatogenesis.

Pharmaceutical form of cortisol, the primary endogenous glucocorticoid.

Kyzatrex is an FDA-approved oral testosterone undecanoate using a lipid-based delivery system requiring ingestion with food.

Third-generation nonsteroidal aromatase inhibitor that reversibly blocks CYP19A1, suppressing estrogen synthesis by 97 to 99%.

Non-ergot dopamine agonist with high D2/D3/D4 selectivity.

Second-generation SERM acting as estrogen agonist in bone and antagonist in breast/uterine tissue.

Non-reversible metabolite of DHEA that does NOT convert to sex hormones, making it unique for immune modulation and metabolic enhancement without a...

First-generation SERM, cornerstone treatment for HR+ breast cancer.

Testosterone enanthate is a long-acting esterified testosterone with a half-life of approximately 4 to 5 days, slightly shorter than cypionate.

Combined oral contraceptive with drospirenone (spironolactone-derived progestin) offering antimineralocorticoid and antiandrogenic properties.

Medisca HRT base, free of alcohols, parabens, and perfumes. Male and female formulations available.

Oral SERM that boosts natural testosterone production while preserving fertility. Alternative to traditional TRT.

Full-spectrum estrogen replacement, oral tablets, transdermal patches, topical creams, and injectable formulations for precise dosing.

Bioidentical progesterone supporting menstrual regulation, sleep quality, and mood. Standard in female hormone protocols alongside estradiol.

Adrenal hormone precursor that converts to testosterone and estrogen. Levels decline with age, replacement supports energy, mood, and libido.

Master hormone precursor that fuels production of nearly all steroid hormones. Supports cognitive function, stress resilience, and hormone balance.

Aromatase inhibitor used in low doses to manage estradiol elevation on TRT. Prevents estrogen-related side effects without over-suppression.

Alpha-glucosidase inhibitor that blunts postprandial glucose spikes.

PPAR-gamma agonist improving insulin sensitivity with significant NASH histologic improvement (PIVENS), cardiovascular risk reduction (PROactive), ...

GLP-1 receptor agonist for sustained weight loss. Reduces appetite, improves glucose control, and supports metabolic health.

First-line antidiabetic with 60+ years of clinical use. Activates AMPK, improves insulin sensitivity, and has emerging interest in longevity protocols.

SGLT2 inhibitor (Farxiga) with FDA approvals across type 2 diabetes, heart failure, and chronic kidney disease. Cardiorenal protection beyond glycemic control.

Norepinephrine-dopamine reuptake inhibitor (NDRI) supporting mood, energy, and appetite control. A non-injectable oral option within weight and wellness protocols.

Synthetic GHRH that stimulates the pituitary to produce its own growth hormone. Gentler, more physiologic approach than exogenous HGH.

Intracavernosal injection combining three vasodilatory agents for erectile dysfunction refractory to oral PDE5 inhibitors.

PDE5 inhibitor with the highest PDE5 selectivity and potency among the class.

Original PDE5 inhibitor. Fast-acting on-demand option for erectile function support.

Melanocortin receptor agonist that works centrally on libido and arousal, distinct mechanism from PDE5 inhibitors. For men and women.

Bioidentical oxytocin nasal spray supporting intimacy, bonding, and arousal. Adjunct to broader hormone optimization protocols.

Xanthine oxidase inhibitor for hyperuricemia.

Long-acting dihydropyridine CCB with 35 to 50 hour half-life.

Irreversible COX-1 inhibitor at low doses providing antiplatelet effects for ASCVD secondary prevention.

First-in-class oral ATP-citrate lyase inhibitor that reduces cholesterol synthesis upstream of HMG-CoA reductase.

Ancient alkaloid with potent anti-inflammatory properties.

Fully human monoclonal antibody targeting PCSK9, dramatically increasing LDL receptor recycling.

PPAR-alpha agonist for hypertriglyceridemia and mixed dyslipidemia.

Long-acting ACE inhibitor with extensive evidence in hypertension, heart failure, post-MI remodeling, and diabetic nephropathy.

Third-generation beta-1 selective blocker with unique NO-enhancing mechanism via beta-3 receptor agonism and eNOS stimulation.

Phospholipid essential for cell membrane integrity and hepatic VLDL assembly.

Long-acting ARB with the longest half-life (~24 hours) of any ARB, providing superior 24-hour BP coverage.

Taurine conjugate of UDCA with greater cytoprotection and bioavailability.

Hydrophilic bile acid that replaces cytotoxic bile acids in the hepatic pool.

High-intensity statin. LDL and ApoB reduction for cardiovascular risk management. Strong outcome data.

Carotenoid antioxidant from Haematococcus pluvialis microalgae, 550x more potent than vitamin E and 6,000x more than vitamin C as a singlet oxygen quencher.

The body's most abundant endogenous antioxidant, declining significantly with age.

Combination of glycine and N-acetyl cysteine that together provide all three amino acid substrates for glutathione synthesis.

Amino acid derivative essential for mitochondrial fatty acid transport (beta-oxidation).

Synergistic combination of vitamin D3 and vitamin K2 (MK-7 form).

mTOR inhibitor with the strongest preclinical longevity data of any compound. Used in pulsed protocols for healthspan and immunity research.

Essential coenzyme for cellular energy and DNA repair. Levels decline with age, direct supplementation supports mitochondrial function and recovery.

Synthetic T4. First-line treatment for hypothyroidism with precise, stable dosing.

Natural desiccated thyroid from porcine glands, supplying both T4 and T3 in a fixed ratio. Each 60mg grain provides 38mcg levothyroxine and 9mcg liothyronine.

Synthetic T3 (Cytomel). Used as an adjunct to T4 for patients with conversion issues or persistent symptoms on levothyroxine alone.

5-alpha reductase inhibitor that blocks DHT production. Standard of care for male pattern hair loss, available as a 1mg or 5mg oral tablet.

Vasodilator that prolongs anagen phase and thickens hair shafts. Available topically and as low-dose oral for broader scalp coverage.

Stronger DHT blocker than finasteride, inhibits both type 1 and type 2 5-alpha reductase. Off-label use for resistant hair loss.

Flavonoid found in chamomile, parsley, and celery with anxiolytic and sleep-promoting properties.

Dual-mechanism cholinesterase inhibitor and allosteric nicotinic receptor modulator.

Phenothiazine dye with unique mitochondrial electron carrier properties.

Off-label low-dose use for sleep onset and maintenance. Non-habit-forming alternative to traditional sleep medications.

Bioidentical melatonin supporting circadian rhythm. Low-dose formulations match physiologic levels for sleep onset without grogginess.

Topical mTORC1 inhibitor for skin anti-aging.

Prescription retinoid (vitamin A derivative) for fine lines, photo-aging, and acne. Gold standard for skin renewal with decades of evidence.

Anti-androgen prescribed for hormonal acne and female pattern hair loss. Blocks androgen receptors at the skin and hair follicle.

Copper tripeptide that stimulates collagen, elastin, and glycosaminoglycan production. Strong evidence for wound healing and anti-aging.

Non-absorbable rifamycin antibiotic acting locally in the GI tract.

Off-label low-dose naltrexone for autoimmune conditions, IBS, and chronic inflammation. Modulates immune response via TLR-4 antagonism.

H2 receptor antagonist reducing stomach acid for reflux, ulcers, and gastritis. Safer long-term profile than PPIs for some patients.

Custom estradiol + progesterone (+/- testosterone) bioidentical hormone replacement for perimenopause and menopause symptoms.

Vaginal suppository used for recurrent yeast infections and bacterial vaginosis that are resistant to standard antifungal therapy.

Naturally occurring simple sugar that prevents E.

FDA-approved combination of doxylamine (antihistamine) and pyridoxine (vitamin B6) for nausea and vomiting of pregnancy (NVP).

Combination of myo-inositol and D-chiro-inositol used primarily for PCOS management.

Mast cell stabilizer that prevents degranulation and mediator release.

Leukotriene receptor antagonist (LTRA) for asthma, allergic rhinitis, and exercise-induced bronchoconstriction.

5-HT3 receptor antagonist for nausea and vomiting prevention.

Prodrug of acyclovir with superior oral bioavailability.

Partial agonist at α4β2 nicotinic acetylcholine receptors, the primary subtype mediating nicotine dependence.